Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Innovation Fund · Direct ✕Aditya Birla Sun Life Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Innovation FundAditya Birla Sun Life Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaABSL
NAV₹15.4407₹41.5400
NAV date20 Nov 202620 Nov 2026
History3.2 years7.4 years
Expense ratio0.9%1.0%
Stars★★★★★★★★★★
Growth Score46.5080.50

Returns

Nippon India Innovation FundAditya Birla Sun Life Pharma and Healthcare Fund
1 month+5.54%+10.45%
3 months−3.05%+2.06%
6 months+8.56%+11.10%
YTD+4.43%+22.61%
1 year+2.54%+21.04%
3 years (CAGR)+13.75%+20.35%
5 years (CAGR)—+16.19%
10 years (CAGR)——
Since launch+14.13%+21.24%

Risk

Nippon India Innovation FundAditya Birla Sun Life Pharma and Healthcare Fund
Volatility17.2%14.6%
Downside volatility11.8%8.5%
Sharpe0.420.95
Sortino0.621.63
Calmar0.641.28
Return / risk0.801.39
Deepest fall−21.47%−20.46%
Days to recover518398
Below its high−3.31%−0.02%

Against benchmark

Nippon India Innovation FundAditya Birla Sun Life Pharma and Healthcare Fund
Alpha+1.93%−0.50%
Beta1.000.94
R²88.2%93.0%
Up capture110.0%92.2%
Down capture105.1%90.9%
Tracking error5.9%3.9%
Information ratio0.33−0.34
Treynor0.060.14

Consistency

Nippon India Innovation FundAditya Birla Sun Life Pharma and Healthcare Fund
Best 1-year+51.67%+72.90%
Middle 1-year+6.12%+18.02%
Worst 1-year−7.68%−15.55%
1-year periods with a loss7.3%19.4%
Middle 3-year+13.78%+19.92%
Positive months72.2%61.1%
Best day+4.00%+3.23%
Worst day−3.85%−2.91%
Worst 5% day−1.59%−1.28%
Positive days56.0%54.9%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Innovation FundAditya Birla Sun Life Pharma and Healthcare Fund
5-year XIRR—+19.85%
5-year value—₹9,93,026
3-year XIRR+8.25%+16.84%
1-year XIRR+9.91%+26.66%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth